[P-PR] (+)RNA

[P-PR-01] Development of a recombinant vaccine against human coronavirus associated severe pneumonia

*Hanako Sekimukai^1,2, Naoko Iwata-Yoshikawa¹, Syuetsu Fukushi³, Aiko Fukuma^3,5, Hideki Tani^4,3, Hideki Hasegawa¹, Noriyo Nagata¹ (1. Department of Pathology, National Institute of Infectious Diseases, 2. Tokyo University of agriculture and technology, 3. Department of Virology I, National Institute of Infectious Diseases, 4. The University of Toyama Department of Virology, 5. Shimane Prefectural Institute of Public Health and Environmental Science)